Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

Clinical trial NCT03948568 · COMPLETED

Trial details

NCT number: NCT03948568
Sponsor: Ottawa Hospital Research Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Early-stage Breast Cancer

Start date: 2019-09-17
Primary completion: 2021-06-09
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.